Skip to main content
. 2020 Nov 30;232:113671. doi: 10.1016/j.ijheh.2020.113671

Table 3.

Symptoms reported by seropositive and -negative study participants.

Seronegative Seropositive p
Typical symptoms, n (%) 597 (54.6) 14 (63.6) 0.52
  • -

    Fever, n (%)

108 (9.9) 8 (36.4) 0.001
  • -

    Cough, n (%)

511 (46.7) 11 (50.0) 0.83
  • -

    Dyspnea, n (%)

254 (23.2) 8 (36.4) 0.12
Rhinorrhea, n (%) 736 (67.3) 16 (72.7) 0.65
Sore throat, n (%) 576 (52.7) 11 (50.0) 0.83
Headache, n (%) 717 (65.5) 15 (68.2) 1.0
Abdominal pain, n (%) 297 (26.9) 8 (36.4) 0.34
Muscle aches, n (%) 247 (22.6) 13 (59.1) <0.001
Nausea, n (%) 211 (19.3) 8 (36.4) 0.06
Diarrhea, n (%) 299 (27.3) 8 (36.4) 0.34

Respective symptoms as stated by the study participants at SP 1 or SP 2 for the preceding month and at SP 3 for the preceding 2 months. Complete information was provided by a total of 1094 seronegative and 22 seropositive participants.